Wells Fargo Maintains Overweight on Stryker, Lowers Price Target to $348

Benzinga Newsdesk www.benzinga.com Negative 86.8%

Neg 86.8% Neu 0% Pos 0%

Wells Fargo analyst Larry Biegelsen maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $418 to $348.